ELTX · Elicio Therapeutics, Inc. · Proposed Sales
$2.05
-0.06 (-2.84%)
At close · Sep 11
Going-concern doubt
— flagged Aug 13, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We are currently facing substantial doubt about our ability to continue as a going concern, given our cash position and cash runway.”View the 10-Q filed Aug 13, 2026
Market Cap
$53.88M
Shares
26.28M
Notices of intent to sell restricted or control shares, filed with the SEC on Form 144 by insiders and affiliates. A Form 144 signals a planned sale — it does not confirm the shares were actually sold.
No Proposed Sales
No Form 144 proposed-sale notices are available for this stock yet.
Key facts
CIK
1601485
CUSIP
28657F103
13F (30d)
19 filings
19 filers
Visit website
Investor relations